Beacon Pharma launched safe IV Iron “Xenofer”
A new drug for intravenous (IV) iron therapy named "Xenofer" has been launched recently by Beacon Pharmaceuticals Ltd., says a press release.
To mark the event, a scientific seminar was held concomitantly at a local hotel in the city. The seminar was on "Role of intravenous (IV) iron therapy in the treatment of iron deficiency anaemia (IDA)".
Professor Dr Mohammed Tahir, Vice Chancellor of Bangabandhu Sheikh Mujib Medical University (BSMMU) chaired the programme while Chairman of Agrani Bank, Siddiqur Rahaman Chowdhury was the chief guest.
Speakers in the seminar focused on the knowledge about the treatment of iron deficiency anaemia, a prevalent preventable disease in the country by IV iron therapy. They said, "IV iron therapy rapidly increases iron level in blood significantly and thereby reduces the morbidity, mortality in women specially the pregnant group who are most vulnerable. They pointed out that iron sucrose present in the drug is currently the safest iron preparation according to latest clinical guideline. It reduces the blood transfusion rates in pregnant women who have severe anaemia near term".
For all latest news, follow The Daily Star's Google News channel.
Comments